Walker MD, Zunt JR. Neuroparasitic infections: cestodes, trematodes and protozoan García HH (Cysticercosis Working Group in Peru). Neurocysticercosis in immigrant populations García HH. Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel.
Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, Hauser WA (Ecuadorian Neurocysti-cercosis Group). Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial Garg RK. Treatment of neurocysticercosis: is it beneficial Kaur S, Singhi P, Singhi S, Khandelwal N. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis. A randomi-zed, placebo-controlled double blind trial White AC. New developments in the management of neurocysticercosis.
Serpa JA, Lancey LS, White AC. Advances in the diagnosis and management of human neurocysti-cercosi Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis. Cysticidal drugs for neurocysticerco-sis: albendazole and praziquantel 14D.10 Schantz PM. Progress in diagnosis, treatment and elimination of echinococcosis and cysticercosis.
14D.11 García HH, Gonzalez AE, Evans CA, Gilman RH (Cysticercosis Working Group in Peru). Taenia so-
14D.12 Carpio A. Neurocysticercosis: an update14D.13 García HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, Herrera G, Evans CA,
Gonzalez AE (Cysticercosis Working Group in Peru). A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosi 14D.14 García HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH. New concepts in the dia-
gnosis and management of neurocysticercosis (Taenia solium) 14D.15 Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T. Subarachnoid basal neurocysticercosis: a
focus on the most severe form of the disease 14D.16 Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosi
14D.17 Garg RK. Antiparasitic treatment for solitary cysticercus granuloma: to treat or not to treat
14D.18 Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizu-
res and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial 14D.19 Proaño JV, Madrazo I, Avelar F, López-Félix B, Díaz G, Grijalva I. Medical treatment for neurocysti-
cercosis characterized by giant subarachnoid cyst 14D.20 Vazquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is gi-
14D.21 Jung H, Hurtado M, Medina MT, Sanchez M, Sotelo J. Dexamethasone increases plasma levels of al-
14D.22 Mitre E, Talaat KR, Sperling MR, Nash TE. Methotrexate as corticosteroid-sparing agent in complica-
14D.23 Junghanss T, da Silva AM, Horton J, Chiodini PL, Brunetti E. Clinical management of cystic echino-
coccosis: state of the art, problems and perspective 14D.24 Brunetti E, Junghanss T. Update on cystic hydatid disease14D.25 Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, García HH, Gavidia CM, Gilman RH, Gon-
zalez AE, Lorca M, Naquira C, Nieto A, Schantz PM. Prevention and control of cystic echinococcosis. 14D.26 Schantz PM. Progress in diagnosis, treatment and elimination of echinococcosis and cysticercosis.
14D.27 Romig T, Dinkel A, Mackenstedt U. The present situation of echinococcosis in Europa
14D.28 Jenkins DJ, Romig T, Thompson RC. Emergence/re-emergence of Echinococcus spp. A global upda-
14D.29 Smego RA, Sebanego P. Treatment options for hepatic cystic echinococcosi
14D.30 Dervenis C, Delis S, Avgerinos C, Madariaga J, Milicevic M. Changing concepts in the management
14D.31 Eckert J, Deplazes P. Biological, epidemiological and clinical aspects of echinococcosis, a zoonosis
14D.32 Smego RA Jr, Bhatti S, Khaliq AA, Beg MA. Percutaneous aspiration, injection, re-aspiration, draina-
ge plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysi 14D.33 Brunetti E, Kern P, Vuitton DA (Writing Panel for the WHO-IWGE). Expert consensus for the diagno-
sis and treatment of cystic and alveolar echinococcosis in humans 14D.34 McManus DP, Zhang W, Li J, Bartley PB. Echinococcosi14D.35 WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar
14D.36 World Health Organization, Department of Communicable Disease, Surveillance and Response.
PAIR: puncture, aspiration, injection, re-aspiration. An option for the treatment of cystic echinococ-
cosis. Available at: Accessed
14D.37 Craig P. Echinococcus multiloculari14D.38 D’Alessandro A, Rausch RL. New aspects of neotropical polycystic (Echinococcus vogeli) and unicys-
tic (Echinococcus oligarthrus) echinococcosi 14D.39 Harhay OM, Horton J, Olliaro PL. Epidemiology and control of human gastrointestinal parasites in
14D.40 Scholz T, Garcia HH, Kuchta R, Wicht B. Update on the human broad tapeworm (genus Diphylloboth-
rium), including clinical relevance 14D.41 Harada S, Nozaki Y, Yagou Y, Hiraga Y, Gatanaga H, Uemura N, Kimura S, Oka S. A woman who
14D.42 Weisse ME, Mullins JK, Moffett KS. A neonate with worm14D.43 Craig P, Ito A. Intestinal cestodes14D.44 Wiwanitkit V. A review of human sparganosis in Thailand


Ocular surface disease handout

OCULAR SURFACE DISEASE HANDOUT Chronic Eyelid Disease – Blepharitis – Dry Eye Syndrome Treatment Plans: _____1.) Drink more water. Goal of 8 – 8 oz glasses a day. More if using caffeine. _____2.) Ocusoft lid wash. Apply a hot, moist wash cloth to eyes for 30 sec. Press on the eyelids to express the glands on both upper and lower lids. Use the cleaning pad by swiping the lids ab

Microsoft word - bera2009_0144.doc

Why does competence in basic calculation matter? Why do primary children differ in it? Richard Cowan1, Chris Donlan2, Donna-Lynn Shepherd1, Rachel Cole-Fletcher1 1Institute of Education University of London, London, United Kingdom, 2University College London, London,United Kingdom Differences between children in mathematicalprogress in primary school have long beenacknowledged to be conside

Copyright © 2014 Medical Pdf Articles